Clinical trial Recruiting at 6 sites Observational Ages 18 and up

Collecting data on the safety and performance of TEKNIMED bone substitutes

Official title: Safety and Clinical Performance Assessment of Bone Substitutes Used for Bone Voids Filling - A Post-Market Clinical Follow-Up

Run by Teknimed · NCT06374342 · Data updated 2026-11-12

This study is testing how safe and effective TEKNIMED's bone substitutes are for patients who have had surgeries that needed these products.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment425 (estimated)
SponsorTeknimed
Industry-sponsored
Locations6 sites (Mainvilliers, Eure et Loir and 5 other locations)
StatusRecruiting
StartedSeptember 16, 2021
Main results expectedSeptember 16, 2026
Study endsSeptember 30, 2032
Registry record updatedSeptember 9, 2025
Trial IDNCT06374342 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are undergoing surgery requiring bone filling with TEKNIMED substitutes.

Probably not a fit

Patients who are pregnant, breastfeeding, or under legal guardianship will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather clinical data on the safety and performance of TEKNIMED's range of bone substitutes, including CERAFORM, TRIHA+, and NANOGEL. It involves both retrospective and prospective data collection from patients who have undergone surgeries requiring these products. The study will follow patients according to local standard medical care, assessing the effectiveness of these synthetic alternatives to traditional bone grafts. The goal is to confirm the safety and efficacy of these products in real-life clinical settings.

Why it matters

Potential benefit: If successful, this study could provide valuable evidence supporting the use of TEKNIMED bone substitutes, potentially improving patient outcomes in bone defect surgeries.

How similar studies have gone: Previous studies have demonstrated the safety and efficacy of synthetic bone substitutes, making this approach consistent with established findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be 18 years or older.
* Be willing to sign an informed consent approved by IRB or EC (where applicable) or not being opposed to the use of their clinical data in the study (France) and

  o For prospective inclusion:
* Be considered for a surgery where bone filling with one of the TEKNIMED bone substitutes comprised in this study is needed and intended to be used according to the IFU.

  o For retrospective inclusion:
* Have undergone a surgery with a TEKNIMED bone substitute used according to the IFU, between the 1st January 2015 and the date of the site initiation visit
* Be informed of the study and not being opposed to the use of their clinical data in the study (France) or be willing to sign an informed consent (where applicable) during the first follow-up visit following the site initiation.

Exclusion Criteria:

Patients presenting one of the following conditions will not be included:

* Under trusteeship or guardianship
* Pregnancy or breast-feeding women

According to contraindications per IFU:

* Procedures other than those stated in the INDICATIONS section
* Patients susceptible to allergic reactions to the product components.

CERAFORM®, TRIHA+®:

\- Treatment of large bone defects which could impact the stability of bone structure without implementing a mechanical stabilisation system (such as plate(s), screw(s), nail(s), cage(s))

NANOGEL®:

* Use in vertebroplasty procedures
* Subcutaneous use

Where it's running

  • Pôle Rachis Hôpital Privé d'Eure et Loir
    Mainvilliers, Eure et Loir, France
    Recruiting
  • Hôpital Joseph Ducuing
    Toulouse, Haute Garonne, France
    Recruiting
  • Clinique Médipole Garonne
    Toulouse, Haute Garonne, France
    Recruiting
  • CHRU Brabois
    Nancy, Meurthe et Moselle, France
    Recruiting
  • Clinique du Pré
    Le Mans, Sarthe, France
    Recruiting
  • OCM Klinik GmbH
    München, Bavaria, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.